Literature DB >> 10653220

Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene.

R Zanardi, F Benedetti, D Di Bella, M Catalano, E Smeraldi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10653220     DOI： 10.1097/00004714-200002000-00021

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  44 in total

Review 1.  Role of pharmacogenomics in individualising treatment with SSRIs.

Authors:  Dalu Mancama; Robert W Kerwin
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Pharmacogenetics in mood disorder.

Authors:  Charles U Nnadi; Joseph F Goldberg; Anil K Malhotra
Journal:  Curr Opin Psychiatry       Date:  2005-01       Impact factor: 4.741

3.  Interaction between the platelet IIb/IIIa receptor gene and serotonin transporter gene is involved in the formation of the predisposition to myocardial infarction in young men.

Authors:  D V Demidova; O V Sirotkina; S V Kudinov; E I Schwartz
Journal:  Dokl Biochem Biophys       Date:  2002 Nov-Dec       Impact factor: 0.788

4.  The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder.

Authors:  L Kathryn Durham; Suzin M Webb; Patrice M Milos; Cathryn M Clary; Albert B Seymour
Journal:  Psychopharmacology (Berl)       Date:  2003-09-04       Impact factor: 4.530

Review 5.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

6.  Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?

Authors:  Ari Illi; Outi Poutanen; Eija Setälä-Soikkeli; Olli Kampman; Merja Viikki; Heini Huhtala; Nina Mononen; Susann Haraldsson; Pasi A Koivisto; Esa Leinonen; Terho Lehtimäki
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-07-17       Impact factor: 5.270

7.  Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.

Authors:  Aarthi Manoharan; Deepak Gopal Shewade; Ravi Philip Rajkumar; Surendiran Adithan
Journal:  Eur J Clin Pharmacol       Date:  2016-07-20       Impact factor: 2.953

8.  A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment.

Authors:  Amira Pierucci-Lagha; Jonathan Covault; Herbert L Bonkovsky; Richard Feinn; Christine Abreu; Richard K Sterling; Robert J Fontana; Henry R Kranzler
Journal:  Psychosomatics       Date:  2010 Mar-Apr       Impact factor: 2.386

Review 9.  Pharmacogenomics and systems biology of membrane transporters.

Authors:  Qing Yan
Journal:  Mol Biotechnol       Date:  2005-01       Impact factor: 2.695

Review 10.  Genetics and psychopharmacology: prospects for individualized treatment.

Authors:  Charles U Nnadi; Joseph F Goldberg; Anil K Malhotra
Journal:  Essent Psychopharmacol       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.